| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000048599 |
| Receipt No. | R000055382 |
| Scientific Title | A study to evaluate the effects of the test food on improving fatigue sensation, sleep quality and cognitive function |
| Date of disclosure of the study information | 2022/08/05 |
| Last modified on | 2022/08/12 (Ver. 2) |
| Basic information | ||
| Public title | A study to evaluate the effects of the test food on improving fatigue sensation, sleep quality and cognitive function | |
| Acronym | A study to evaluate the effects of the test food on improving fatigue sensation, sleep quality and cognitive function | |
| Scientific Title | A study to evaluate the effects of the test food on improving fatigue sensation, sleep quality and cognitive function | |
| Scientific Title:Acronym | A study to evaluate the effects of the test food on improving fatigue sensation, sleep quality and cognitive function | |
| Region |
|
|
| Condition | |||
| Condition | Healthy volunteers | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To examine the effects of the test food on improving fatigue sensation, sleep quality and. cognitive function |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | VAS (fatigue sensation) |
| Key secondary outcomes | VAS (eyestrain, sleepiness, motivation, concentration), Jikaku-sho shirabe, OSA sleep inventory MA version, The St. Mary's Hospital sleep questionnaire, Karolinska Sleepiness Scale Japanese version, POMS2 Japanese version, work performance, cognitive function test, autonomic nervous function, vascular state, sleep and activity tracker, urinalysis, blood analysis |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Intake of test food for 4 weeks -> Washout period ( 4 week) -> Intake of placebo for 4 weeks | |
| Interventions/Control_2 | Intake of placebo for 4 weeks -> Washout period ( 4 week) -> Intake of test food for 4 weeks | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) Males and females whose age of 20 years or more and less than 65 years
2) Subjects who perceive fatigue sensation in daily work 3) Subjects receiving a sufficient briefing of the objective and content of the present study, fully understanding and agreeing to voluntarily participate in the study and being able to personally sign a written informed consent |
|||
| Key exclusion criteria | 1) Subjects receiving a medical treatment for serious cardio-vascular, hepatic, renal, respiratory, endocrine or metabolic disorders or having a medical history of these disorders
2) Subjects with chronic fatigue syndrome (CFS) , or subjects deemed to have severe fatigue such as idiopathic chronic fatigue by the investigator 3) Subjects who take regularly medicines and quasi-drugs having the effects on fatigue sensation, sleep quality and cognitive function 4) Subjects who take regularly Food with Functional Claims having the effects on fatigue sensation, sleep quality and cognitive function 5) Subjects whose lifestyles are irregular because of night shift or others 6) Subjects having blood sample of 200 ml or more taken within 1 month, or 400 ml or more within 3 months prior to the start of the present study (e.g. donated blood) 7) Subjects who have the possibility of developing allergic symptoms by the test food 8) Subjects who are pregnant or lactating, or intending to become pregnant during the study 9) Subjects who took part in another clinical study within 3 months prior to the start of the present study or who is currently taking part in another clinical study 10) Subjects deemed unsuitable by the investigator |
|||
| Target sample size | 24 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Japan Preventive Medicine Inc. | ||||||
| Division name | Research and Development | ||||||
| Zip code | 5600082 | ||||||
| Address | Senri Life Science Center 14F, 1-4-2, Shinsenri-higashimachi, Toyonaka, Osaka | ||||||
| TEL | 06-6831-3383 | ||||||
| takigami@japanpm.com | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Japan Preventive Medicine Inc. | ||||||
| Division name | Research and Development | ||||||
| Zip code | 5600082 | ||||||
| Address | Senri Life Science Center 14F, 1-4-2, Shinsenri-higashimachi, Toyonaka, Osaka | ||||||
| TEL | 06-6831-3383 | ||||||
| Homepage URL | |||||||
| takigami@japanpm.com | |||||||
| Sponsor | |
| Institute | Japan Preventive Medicine Inc. |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | IRB of Fukuda Clinic |
| Address | Shin-Osaka brick building 2F, 1-6- 1 Miyahara, Yodogawa, Osaka, Osaka |
| Tel | 06-6398-0203 |
| fukudaclinicIRB@gmail.com | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 医療法人弘正会ふくだ内科クリニック(大阪府) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB | |||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000055382 |